[1]
“Review on rise of sister disease in type-II Diabetic patients”, Int. J. of Res. in Pharmacology &Pharmacotherapeutics , vol. 4, no. 4, pp. 416–421, Apr. 2021, doi: 10.61096/ijrpp.v4.iss4.2015.416-421.